OPKO Biologics Sustainability Profile
OPKO Biologics, a subsidiary of OPKO Health, Inc., is a prominent player in the biotechnology industry, headquartered in Illinois. Founded in 2007, the company has made significant strides in the development of innovative biologic therapies, particularly in the fields of protein therapeutics and drug delivery systems. With a focus on advanced biologics, OPKO Biologics offers unique products that leverage proprietary technologies to enhance therapeutic efficacy. The company is recognised for its commitment to research and development, positioning itself as a leader in the biopharmaceutical sector. Notable achievements include successful collaborations and advancements in drug formulation, which have solidified its reputation in the market. As OPKO Biologics continues to expand its operational reach, it remains dedicated to improving patient outcomes through cutting-edge biotechnological solutions.
DitchCarbon Score
How does OPKO Biologics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
OPKO Biologics's score of 25 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
OPKO Biologics's reported carbon emissions
OPKO Biologics, headquartered in Illinois (IL), currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of OPKO Health, Inc., which may influence its climate commitments and emissions reporting. As of now, OPKO Biologics has not established any documented reduction targets or climate pledges. The absence of specific emissions data and reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given the lack of direct emissions data, it is important to note that OPKO Biologics' climate commitments may be informed by broader initiatives from its parent company, OPKO Health, Inc. However, specific details regarding these initiatives or any cascading emissions data from OPKO Health, Inc. have not been provided. In summary, OPKO Biologics is currently without specific emissions data or reduction targets, indicating a potential area for future development in their climate strategy.
How Carbon Intensive is OPKO Biologics's Industry?
How Carbon Intensive is OPKO Biologics's Location?
OPKO Biologics's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
OPKO Biologics has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
